Department of Internal Medicine, School of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Global Health, Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden;
Department of Internal Medicine, School of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Glob Health Action. 2014 Feb 25;7:22853. doi: 10.3402/gha.v7.22853. eCollection 2014.
HIV/AIDS continues to destroy the lives of young people especially in low-income countries. The inclusion of youths in HIV vaccine trials is of utmost importance in obtaining an effective vaccine that is acceptable to them.
To characterize the willingness of young adults in Tanzania to participate in an HIV vaccine trial and the factors that influence this willingness.
Four hundred and fifty young adults who visited a youth-friendly Infectious Diseases Clinic (IDC) from February 2012 to September 2012 completed a self-administered questionnaire concerning sociodemographic information, their knowledge about and perception of HIV vaccine studies, and the availability of social support.
Of our participants, 50.6% expressed willingness to participate in HIV vaccine trials, and this willingness was positively correlated with having some knowledge about HIV vaccine studies (AOR, 2.2; 95% CI: 1.4-3.4), a positive perception toward such studies (AOR, 2.3; 95% CI: 1.5-3.6), having a relationship with someone who could help them make a decision (AOR, 2.5; 95% CI: 1.3-4.9), and age at the time of sexual debut (AOR, 2.6; 95% CI 1.0-6.7) for 15- to 19-year-olds and (AOR, 2.7; 95% CI 1.0-7.1) for older participants.
The participants exhibited a moderate willingness to participate in HIV vaccine trials, which was associated with a positive perception of and some knowledge about such trials, having a relationship with someone who might influence their decision as well as age at time of sexual debut. More efforts should be made to inform the youths about specific HIV vaccine trials and related matters, as well as to engage significant others in the decision-making process.
艾滋病毒/艾滋病继续摧毁年轻人的生命,尤其是在低收入国家。让年轻人参与艾滋病毒疫苗试验至关重要,因为只有这样才能获得一种对他们有效的疫苗。
描述坦桑尼亚青年参与艾滋病毒疫苗试验的意愿,并分析影响这种意愿的因素。
2012 年 2 月至 9 月,450 名青年在一个青年友好型传染病诊所(IDCs)就诊,他们完成了一份自我管理问卷,内容包括社会人口学信息、他们对艾滋病毒疫苗研究的了解和看法以及社会支持的可用性。
在我们的参与者中,50.6%表示愿意参加艾滋病毒疫苗试验,这种意愿与对艾滋病毒疫苗研究有一定的了解呈正相关(优势比,2.2;95%可信区间:1.4-3.4),对这些研究的看法积极(优势比,2.3;95%可信区间:1.5-3.6),与能够帮助他们做出决定的人有关系(优势比,2.5;95%可信区间:1.3-4.9),以及初次性行为的年龄(优势比,2.6;95%可信区间 1.0-6.7)对于 15 至 19 岁的参与者,和(优势比,2.7;95%可信区间 1.0-7.1)对于年龄较大的参与者。
参与者表现出适度的参与艾滋病毒疫苗试验的意愿,这与对这些试验的积极看法和一定的了解、与可能影响他们决策的人的关系以及初次性行为的年龄有关。应该做出更多努力,向年轻人通报具体的艾滋病毒疫苗试验和相关事项,并让重要他人参与决策过程。